Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy China SXT Pharmaceuticals stock

Own China SXT Pharmaceuticals stock in just a few minutes.

China SXT Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. China SXT Pharmaceuticals shares (SXTC) are listed on the NASDAQ and all prices are listed in US Dollars. China SXT Pharmaceuticals employs 97 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in China SXT Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SXTC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

China SXT Pharmaceuticals share price

Use our graph to track the performance of SXTC stocks over time.

China SXT Pharmaceuticals shares at a glance

Information last updated 2021-03-10.
52-week range$0.89 - $5.12
50-day moving average $2.83
200-day moving average $1.65
Wall St. target priceN/A
PE ratio 12.5053
Dividend yield N/A (0%)
Earnings per share (TTM) $0.08

Buy China SXT Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy China SXT Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is China SXT Pharmaceuticals under- or over-valued?

Valuing China SXT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China SXT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

China SXT Pharmaceuticals's P/E ratio

China SXT Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, China SXT Pharmaceuticals shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

China SXT Pharmaceuticals's EBITDA

China SXT Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $424,668.

The EBITDA is a measure of a China SXT Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

China SXT Pharmaceuticals financials

Revenue TTM $5.8 million
Operating margin TTM 0.75%
Gross profit TTM $2.7 million
Return on assets TTM 0.12%
Return on equity TTM -43.83%
Profit margin -112.93%
Book value $1.19
Market capitalisation $28.6 million

TTM: trailing 12 months

Shorting China SXT Pharmaceuticals shares

There are currently 327,342 China SXT Pharmaceuticals shares held short by investors – that's known as China SXT Pharmaceuticals's "short interest". This figure is 9.2% down from 360,558 last month.

There are a few different ways that this level of interest in shorting China SXT Pharmaceuticals shares can be evaluated.

China SXT Pharmaceuticals's "short interest ratio" (SIR)

China SXT Pharmaceuticals's "short interest ratio" (SIR) is the quantity of China SXT Pharmaceuticals shares currently shorted divided by the average quantity of China SXT Pharmaceuticals shares traded daily (recently around 2.5 million). China SXT Pharmaceuticals's SIR currently stands at 0.13. In other words for every 100,000 China SXT Pharmaceuticals shares traded daily on the market, roughly 130 shares are currently held short.

However China SXT Pharmaceuticals's short interest can also be evaluated against the total number of China SXT Pharmaceuticals shares, or, against the total number of tradable China SXT Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case China SXT Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 China SXT Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0.022% of the tradable shares (for every 100,000 tradable China SXT Pharmaceuticals shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against China SXT Pharmaceuticals.

Find out more about how you can short China SXT Pharmaceuticals stock.

China SXT Pharmaceuticals share dividends

We're not expecting China SXT Pharmaceuticals to pay a dividend over the next 12 months.

Have China SXT Pharmaceuticals's shares ever split?

China SXT Pharmaceuticals's shares were split on a 1:4 basis on 21 February 2021. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your China SXT Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for China SXT Pharmaceuticals shares which in turn could have impacted China SXT Pharmaceuticals's share price.

China SXT Pharmaceuticals share price volatility

Over the last 12 months, China SXT Pharmaceuticals's shares have ranged in value from as little as $0.888 up to $5.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China SXT Pharmaceuticals's is -0.231. This would suggest that China SXT Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, China SXT Pharmaceuticals has bucked the trend.

China SXT Pharmaceuticals overview

China SXT Pharmaceuticals, Inc. , a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of May 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. The company was founded in 2005 and is based in Taizhou, China. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site